CalciMedica, Inc. (CALC): Free Cash Flow
-$21.21M
Year ended 2025-12-31
-$18.20M
Trailing 12 months to 2026-09-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$21.21M | n/m | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | -$21.15M | n/m | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | -$25.81M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$11.76M | n/c | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$31.99M | n/m | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | -$33.09M | n/m | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | -$31.82M | n/a | 2021-03-05, From 2019-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$21.21M | n/m |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | -$11.13M | n/m |
| Exicure, Inc. (XCUR) | 2025-12-31 | -$8.56M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2024-12-31 | -$10.64M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | -$6.38M | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | -$5.69M | n/a |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | -$23.12M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | -$14.18M | n/m |
| Cingulate Inc. (CING) | 2025-12-31 | -$17.41M | n/m |
Compare CALC, CMMB, XCUR, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗